CLEW Medical For Profit

CLEW is a healthcare company that provides AI-driven, FDA-cleared predictive analytics for high-acuity care. Their peer-reviewed predictive insights have been documented to be at least five times more accurate than other systems. They offer truly accurate predictions of patient deterioration, up to eight hours before patient monitoring systems would suspect, which gives hospitals and health systems the opportunity for early intervention. This leads to decreases in mortality and reductions in complications and readmissions. Early identification of patient deterioration allows caregivers time to intervene proactively, which leads to decreases in unforeseen bottlenecks, reducing length of stay, improving capacity management, and access to care. CLEW offers hospitals, healthcare systems, and intensive care units advanced clinical intelligence and patient diagnostics using AI-powered, FDA-cleared predictive analytics and proprietary critical care models. Contact_info: info@clewmed.com

Founded Date: 2014-01-01
Total Funding: 20500000.0
Investor Type: N/A
Employee Number: 11-50
Investment Stage: N/A
Funding Status: Early Stage Venture
Number Of Exists: N/A
Technology: Biomarker panels
Last Funding Type: Series B
Last Funding Date: 2020-01-15
Industry: Clinical Data Management
Headquarters: Ramat Poleg, HaMerkaz, Israel